Primary Site >> Pancreatic Cancer
Gene >> CSPG4
| 1. | |||||||||||
| Journal: | Cancer Biol Ther. 2006 Dec;5(12):1640-6. Epub 2006 Dec 5. | ||||||||||
| Title: | Identification of fibroblast heterogeneity in the tumor microenvironment. | ||||||||||
| Author: | Sugimoto, Hikaru|Mundel, Thomas M|Kieran, Mark W|Kalluri, Raghu | ||||||||||
| PMID: | 17106243 | ||||||||||
| 2. | |||||||||||
| Journal: | Mol Cancer Ther. 2013 Jun;12(6):992-1001. | ||||||||||
| Title: | BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer. | ||||||||||
| Author: | Kutluk Cenik, Bercin|Ostapoff, Katherine T|Gerber, David E|Brekken, Rolf A | ||||||||||
| PMID: | 23729403 | ||||||||||
| 3. | |||||||||||
| Journal: | PLoS One. 2014 Jun 16;9(6):e100178. | ||||||||||
| Title: | Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors. | ||||||||||
| Author: | Keleg, Shereen|Titov, Alexandr|Heller, Anette|Giese, Thomas|Tjaden, Christine|Ahmad, Sufian S|Gaida, Matthias M|Bauer, Andrea S|Werner, Jens|Giese, Nathalia A | ||||||||||
| PMID: | 24932730 | ||||||||||